Yutaka Niihara - Net Worth and Insider Trading
Yutaka Niihara Net Worth
The estimated net worth of Yutaka Niihara is at least $170,753 dollars as of 2025-01-15. Yutaka Niihara is the Chairman and CEO, 10% Owner of Emmaus Life Sciences Inc and owns about 12,196,651 shares of Emmaus Life Sciences Inc (EMMA) stock worth over $170,753. Details can be seen in Yutaka Niihara's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yutaka Niihara has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yutaka Niihara
Yutaka Niihara Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yutaka Niihara owns 1 companies in total, including Emmaus Life Sciences Inc (EMMA) .
Click here to see the complete history of Yutaka Niihara’s form 4 insider trades.
Insider Ownership Summary of Yutaka Niihara
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EMMA | Emmaus Life Sciences Inc | 2022-11-30 | director & 10 percent owner & Chairman and CEO |
Yutaka Niihara Latest Holdings Summary
Yutaka Niihara currently owns a total of 1 stock. Yutaka Niihara owns 12,196,651 shares of Emmaus Life Sciences Inc (EMMA) as of November 30, 2022, with a value of $170,753.
Latest Holdings of Yutaka Niihara
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EMMA | Emmaus Life Sciences Inc | 2022-11-30 | 12,196,651 | 0.01 | 170,753 |
Holding Weightings of Yutaka Niihara
Yutaka Niihara Form 4 Trading Tracker
According to the SEC Form 4 filings, Yutaka Niihara has made a total of 105 transactions in Emmaus Life Sciences Inc (EMMA) over the past 5 years, including 105 buys and 0 sells. The most-recent trade in Emmaus Life Sciences Inc is the acquisition of 52,600 shares on November 30, 2022, which cost Yutaka Niihara around $21,040.
Insider Trading History of Yutaka Niihara
- 1
Yutaka Niihara Trading Performance
GuruFocus tracks the stock performance after each of Yutaka Niihara's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yutaka Niihara is -1.41%. GuruFocus also compares Yutaka Niihara's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yutaka Niihara within 3 months outperforms 35 times out of 118 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yutaka Niihara's insider trading performs compared to the benchmark.
Performance of Yutaka Niihara
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.99 | | | | | |
| Relative Return to S&P 500(%) | 1.76 | | | | | |
Yutaka Niihara Ownership Network
Ownership Network List of Yutaka Niihara
Ownership Network Relation of Yutaka Niihara
Yutaka Niihara Owned Company Details
What does Emmaus Life Sciences Inc do?
Who are the key executives at Emmaus Life Sciences Inc?
Yutaka Niihara is the director & 10 percent owner & Chairman and CEO of Emmaus Life Sciences Inc. Other key executives at Emmaus Life Sciences Inc include director & Vice Chairman & COO Willis C Lee , CIO & SVP George Sekulich , and SVP & Clinical Development Charles William Stark .
Emmaus Life Sciences Inc (EMMA) Insider Trades Summary
Over the past 18 months, Yutaka Niihara made no insider transaction in Emmaus Life Sciences Inc (EMMA). Other recent insider transactions involving Emmaus Life Sciences Inc (EMMA) include a net purchase of 120,700 shares made by Seah H. Lim , and a net purchase of 251,809 shares made by Willis C Lee .
In summary, during the past 3 months, insiders sold 0 shares of Emmaus Life Sciences Inc (EMMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 38,500 shares of Emmaus Life Sciences Inc (EMMA) were sold and 411,009 shares were bought by its insiders, resulting in a net purchase of 372,509 shares.
Emmaus Life Sciences Inc (EMMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Emmaus Life Sciences Inc Insider Transactions
Yutaka Niihara Mailing Address
Above is the net worth, insider trading, and ownership report for Yutaka Niihara. You might contact Yutaka Niihara via mailing address: 20725 S. Western Blvd., Suite 136, Torrance Ca 90501.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
